CAS RN: 102767-28-2 | Product Number: L0234
*Upon orders receipt, Hyderabad stocks will be dispatched on the same day & Chennai stocks will be dispatched in 3-6 working days.
*Items available in Japan warehouse will be dispatched in 10-12 working days.
*INR price is exclusive of domestic taxes applicable.
*Change currency to place order in USD.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
|Appearance||White to Almost white powder to crystal|
|Purity(HPLC)||min. 98.0 area%|
|Purity(with Total Nitrogen)||min. 98.0 %|
|Melting point||116.0 to 120.0 °C|
|Specific rotation [a]20/D||-86.0 to -90.0 deg(C=1, Acetone)|
|Melting Point||118 °C|
|Specific Rotation||-88° (C=1,Acetone)|
|Solubility (soluble in)||Acetone|
|Hazard Statements||H302 : Harmful if swallowed.
H319 : Causes serious eye irritation.
|Precautionary Statements||P501 : Dispose of contents/ container to an approved waste disposal plant.
P270 : Do not eat, drink or smoke when using this product.
P264 : Wash skin thoroughly after handling.
P280 : Wear eye protection/ face protection.
P337 + P313 : If eye irritation persists: Get medical advice/ attention.
P305 + P351 + P338 : IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth.
- Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobe epilepsy
- W. Loscher, D. Honack, C. Rundfeldt, J. Pharmacol. Exp. Ther. 1998, 284, 474.
- The novel antiepileptic drug levetiracetam (ucb L059) appears to act via a specific binding site in CNS membranes
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
C of A & Other Certificates
The requested analytical chart is not available. Sorry for the inconvenience.